Interplay between glucocorticoids and tumor-infiltrating lymphocytes on the prognosis of adrenocortical carcinoma

被引:72
|
作者
Landwehr, Laura-Sophie [1 ]
Altieri, Barbara [1 ]
Schreiner, Jochen [1 ]
Sbiera, Iuliu [1 ]
Weigand, Isabel [1 ]
Kroiss, Matthias [1 ,2 ]
Fassnacht, Martin [1 ,2 ,3 ]
Sbiera, Silviu [1 ,2 ]
机构
[1] Univ Hosp Wurzburg, Dept Internal Med 1, Div Endocrinol & Diabet, Wurzburg, Germany
[2] Univ Wurzburg, Comprehens Canc Ctr Mainfranken, Wurzburg, Germany
[3] Univ Hosp Wurzburg, Clin Chem & Lab Med, Wurzburg, Germany
关键词
immunity; immunotherapy; lymphocytes; tumor-infiltrating; t-lymphocytes; tumor microenvironment; REGULATORY T-CELLS; EUROPEAN-SOCIETY; PHASE-II; CANCER; COLLABORATION; PEMBROLIZUMAB; MANAGEMENT; NIVOLUMAB; SURVIVAL; EFFICACY;
D O I
10.1136/jitc-2019-000469
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Adrenocortical carcinoma (ACC) is a rare endocrine malignancy. Tumor-related glucocorticoid excess is present in similar to 60% of patients and associated with particularly poor prognosis. Results of first clinical trials using immune checkpoint inhibitors were heterogeneous. Here we characterize tumor-infiltrating T lymphocytes (TILs) in ACC in association with glucocorticoids as potential explanation for resistance to immunotherapy. Methods We performed immunofluorescence analysis to visualize tumor-infiltrating T cells (CD3(+)), T helper cells (CD3(+)CD4(+)), cytotoxic T cells (CD3(+)CD8(+)) and regulatory T cells (Tregs; CD3(+)CD4(+)FoxP3(+)) in 146 ACC tissue specimens (107 primary tumors, 16 local recurrences, 23 metastases). Quantitative data of immune cell infiltration were correlated with clinical data (including glucocorticoid excess). Results 86.3% of ACC specimens showed tumor infiltrating T cells (7.7 cells/high power field (HPF)), including T helper (74.0%, 6.7 cells/HPF), cytotoxic T cells (84.3%, 5.7 cells/HPF) and Tregs (49.3%, 0.8 cells/HPF). The number of TILs was associated with better overall survival (HR for death: 0.47, 95% CI 0.25 to 0.87), which was true for CD4(+)- and CD8(+) subpopulations as well. In localized, non-metastatic ACC, the favorable impact of TILs on overall and recurrence-free survival was manifested even independently of ENSAT (European Network for the Study of Adrenal Tumors) stage, resection status and Ki67 index. T helper cells were negatively correlated with glucocorticoid excess (Phi=-0.290, p=0.009). Patients with glucocorticoid excess and low TILs had a particularly poor overall survival (27 vs. 121 months in patients with TILs without glucocorticoid excess). Conclusion Glucocorticoid excess is associated with T cell depletion and unfavorable prognosis. To reactivate the immune system in ACC by checkpoint inhibitors, an inhibition of adrenal steroidogenesis might be pivotal and should be tested in prospective studies.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] The emergence of tumor-infiltrating lymphocytes in nasopharyngeal carcinoma: Predictive value and immunotherapy implications
    Yang, Liu
    Liu, Guohong
    Li, Yirong
    Pan, Yunbao
    GENES & DISEASES, 2022, 9 (05) : 1208 - 1219
  • [42] Identification of tumor-infiltrating lymphocyte subpopulations correlated with patient prognosis in esophageal squamous cell carcinoma
    Peng, Lin
    He, Wenwu
    Ye, Feng
    Song, Yane
    Shi, Xinying
    Zhang, Jiao
    Li, Qingyun
    Fang, Qiang
    Xiao, Wenguang
    Han, Yongtao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (05)
  • [43] Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma A meta-analysis
    Ding, Wei
    Xu, Xuezhong
    Qian, Yan
    Xue, Wenbo
    Wang, Yibo
    Du, Jianguo
    Jin, Lei
    Tan, Yulin
    MEDICINE, 2018, 97 (50)
  • [44] Do tumor-infiltrating lymphocytes really indicate favorable prognosis in epithelial ovarian cancer?
    Yildirim, Nuri
    Akman, Levent
    Acar, Kamuran
    Demir, Sibel
    Ozkan, Sultan
    Alan, Nuran
    Zekioglu, Osman
    Terek, M. Cosan
    Ozdemir, Necmettin
    Ozsaran, Aydin
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2017, 215 : 55 - 61
  • [45] Evaluation of tumor-infiltrating lymphocytes in osteosarcomas of the jaws: a multicenter study
    Alves, Pollianna Muniz
    Almeida de Arruda, Jose Alcides
    Costa Arantes, Diego Antonio
    Santos Costa, Sara Ferreira
    Souza, Lucas Lacerda
    Rebelo Pontes, Helder Antonio
    Fonseca, Felipe Paiva
    Mesquita, Ricardo Alves
    Weege Nonaka, Cassiano Francisco
    Mendonca, Elismauro Francisco
    Batista, Aline Carvalho
    VIRCHOWS ARCHIV, 2019, 474 (02) : 201 - 207
  • [46] Relevance of tumor-infiltrating lymphocytes in breast cancer
    Sathana Dushyanthen
    Paul A. Beavis
    Peter Savas
    Zhi Ling Teo
    Chenhao Zhou
    Mariam Mansour
    Phillip K. Darcy
    Sherene Loi
    BMC Medicine, 13
  • [47] Immunohistochemical analysis of tumor-infiltrating lymphocytes in breast carcinoma: Relation to prognostic variables
    Helal, Thanaa E. A.
    Ibrahim, Eman A. A.
    Alloub, Amal I. A.
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2013, 56 (02) : 89 - 93
  • [48] Machine learning for MRI radiomics: a study predicting tumor-infiltrating lymphocytes in patients with pancreatic ductal adenocarcinoma
    Bian, Yun
    Liu, Yan Fang
    Jiang, Hui
    Meng, Yinghao
    Liu, Fang
    Cao, Kai
    Zhang, Hao
    Fang, Xu
    Li, Jing
    Yu, Jieyu
    Feng, Xiaochen
    Li, Qi
    Wang, Li
    Lu, Jianping
    Shao, Chengwei
    ABDOMINAL RADIOLOGY, 2021, 46 (10) : 4800 - 4816
  • [49] Tumor-infiltrating lymphocytes in breast FNA biopsy cytology: a predictor of tumor-infiltrating lymphocytes in histologic evaluation
    Odate, Toru
    Le, Minh-Khang
    Kawai, Masataka
    Kubota, Mizuki
    Yamaguchi, Yohei
    Kondo, Tetsuo
    CANCER CYTOPATHOLOGY, 2022, 130 (05) : 336 - 343
  • [50] Perivascular Tumor-Infiltrating Leukocyte Scoring for Prognosis of Resected Hepatocellular Carcinoma Patients
    Schoenberg, Markus Bo
    Hao, Jingcheng
    Bucher, Julian Nikolaus
    Miksch, Rainer Christoph
    Anger, Hubertus Johann Wolfgang
    Mayer, Barbara
    Mayerle, Julia
    Neumann, Jens
    Guba, Markus Otto
    Werner, Jens
    Bazhin, Alexandr, V
    CANCERS, 2018, 10 (10)